Model-based investigation of the transcriptional activity of p53 and its feedback loop regulation via 14-3-3σ.
暂无分享,去创建一个
O. Wolkenhauer | S. Nikolov | J. Vera | Xin Lai | A. Singh
[1] L. Boise,et al. Farnesyl transferase inhibitors, autophagy, and proteasome inhibition: Synergy for all the right reasons , 2011, Autophagy.
[2] Jean-Luc Gouzé,et al. A Theoretical Exploration of Birhythmicity in the p53-Mdm2 Network , 2011, PloS one.
[3] M. White,et al. Spatial and temporal information coding and noise in the NF-κB system. , 2010, Biochemical Society transactions.
[4] K. Nüsslein,et al. Phytoprotective influence of bacteria on growth and cadmium accumulation in the aquatic plant Lemna minor. , 2010, Water research.
[5] John J Tyson,et al. A model of yeast cell-cycle regulation based on multisite phosphorylation , 2010, Molecular systems biology.
[6] U. Alon,et al. Fourier analysis and systems identification of the p53 feedback loop , 2010, Proceedings of the National Academy of Sciences.
[7] M. Kaufman,et al. From structure to dynamics: frequency tuning in the p53-Mdm2 network. II Differential and stochastic approaches. , 2010, Journal of theoretical biology.
[8] Olaf Wolkenhauer,et al. Integration of sensitivity and bifurcation analysis to detect critical processes in a model combining signalling and cell population dynamics , 2010, Int. J. Syst. Sci..
[9] Olaf Wolkenhauer,et al. Dynamical effects of epigenetic silencing of 14-3-3sigma expression. , 2009, Molecular bioSystems.
[10] Sandeep Krishna,et al. Stress-specific response of the p53-Mdm2 feedback loop , 2010, BMC Systems Biology.
[11] Markus Kirkilionis,et al. Bistability and oscillations in chemical reaction networks , 2009, Journal of mathematical biology.
[12] J. Vera,et al. 14-3-3σ gene silencing during melanoma progression and its role in cell cycle control and cellular senescence , 2009, Molecular Cancer.
[13] Z. Cheng,et al. Cell fate decision mediated by p53 pulses , 2009, Proceedings of the National Academy of Sciences.
[14] M. Kaufman,et al. From structure to dynamics: frequency tuning in the p53-Mdm2 network I. Logical approach. , 2009, Journal of theoretical biology.
[15] C. Prives,et al. Blinded by the Light: The Growing Complexity of p53 , 2009, Cell.
[16] D. S. Broomhead,et al. Pulsatile Stimulation Determines Timing and Specificity of NF-κB-Dependent Transcription , 2009, Science.
[17] Alexei A. Sharov,et al. Database for mRNA Half-Life of 19 977 Genes Obtained by DNA Microarray Analysis of Pluripotent and Differentiating Mouse Embryonic Stem Cells , 2008, DNA research : an international journal for rapid publication of reports on genes and genomes.
[18] J. Tyson,et al. Design principles of biochemical oscillators , 2008, Nature Reviews Molecular Cell Biology.
[19] Qikai Xu,et al. Global Protein Stability Profiling in Mammalian Cells , 2008, Science.
[20] Tomasz Lipniacki,et al. Oscillations and bistability in the stochastic model of p53 regulation. , 2008, Journal of theoretical biology.
[21] J. R. Pomerening,et al. Uncovering mechanisms of bistability in biological systems. , 2008, Current opinion in biotechnology.
[22] H. Westerhoff,et al. Recurrent design patterns in the feedback regulation of the mammalian signalling network , 2008, Molecular systems biology.
[23] Eduardo Sontag,et al. Transcriptional control of human p53-regulated genes , 2008, Nature Reviews Molecular Cell Biology.
[24] K. Langer,et al. Downregulation of Plk1 expression by receptor-mediated uptake of antisense oligonucleotide-loaded nanoparticles. , 2008, Neoplasia.
[25] M.-H. Lee,et al. Roles for negative cell regulator 14-3-3σ in control of MDM2 activities , 2007, Oncogene.
[26] E. Kass,et al. Stability of Checkpoint Kinase 2 Is Regulated via Phosphorylation at Serine 456* , 2007, Journal of Biological Chemistry.
[27] Chao Zhang,et al. Suppression of p53-dependent senescence by the JNK signal transduction pathway , 2007, Proceedings of the National Academy of Sciences.
[28] G. Behre,et al. Proteomic identification of C/EBP-DBD multiprotein complex: JNK1 activates stem cell regulator C/EBPα by inhibiting its ubiquitination , 2007, Oncogene.
[29] Paul Brazhnik,et al. Exploring Mechanisms of the DNA-Damage Response: p53 Pulses and their Possible Relevance to Apoptosis , 2007, Cell cycle.
[30] Michael Q. Zhang,et al. TRED: a transcriptional regulatory element database, new entries and other development , 2007, Nucleic Acids Res..
[31] M.-H. Lee,et al. Roles for negative cell regulator 14-3-3sigma in control of MDM2 activities. , 2007, Oncogene.
[32] Alnawaz Rehemtulla,et al. Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imaging. , 2006, Cancer research.
[33] R. Milo,et al. Oscillations and variability in the p53 system , 2006, Molecular systems biology.
[34] Wei Gu,et al. p53 ubiquitination: Mdm2 and beyond. , 2006, Molecular cell.
[35] Yun-Wei Lin,et al. Cooperation of ERK and SCFSkp2 for MKP-1 Destruction Provides a Positive Feedback Regulation of Proliferating Signaling* , 2006, Journal of Biological Chemistry.
[36] John Jeremy Rice,et al. A plausible model for the digital response of p53 to DNA damage. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[37] C. Fenoglio-Preiser,et al. Stability of Phosphoprotein as a Biological Marker of Tumor Signaling , 2005, Clinical Cancer Research.
[38] D. Lodygin,et al. The role of epigenetic inactivation of 14-3-3σ in human cancer , 2005, Cell Research.
[39] Xingming Deng,et al. Nicotine Inactivation of the Proapoptotic Function of Bax through Phosphorylation* , 2005, Journal of Biological Chemistry.
[40] Andrea Ciliberto,et al. Steady States and Oscillations in the p53/Mdm2 Network , 2005, Cell cycle.
[41] D. Lodygin,et al. The role of epigenetic inactivation of 14-3-3sigma in human cancer. , 2005, Cell research.
[42] E. W. Jacobsen,et al. Linear systems approach to analysis of complex dynamic behaviours in biochemical networks. , 2004, Systems biology.
[43] K. Horie-Inoue,et al. 14-3-3σ is down-regulated in human prostate cancer , 2004 .
[44] Uri Alon,et al. Dynamics of the p53-Mdm2 feedback loop in individual cells , 2004, Nature Genetics.
[45] C. Acquaviva,et al. Complex mechanisms for c-fos and c-jun degradation , 1997, Molecular Biology Reports.
[46] R. Halaban,et al. The tyrphostin AG1024 accelerates the degradation of phosphorylated forms of retinoblastoma protein (pRb) and restores pRb tumor suppressive function in melanoma cells. , 2003, Cancer research.
[47] J. Sherratt,et al. Cells behaving badly: a theoretical model for the Fas/FasL system in tumour immunology. , 2002, Mathematical biosciences.
[48] Satoshi Inoue,et al. Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth , 2002, Nature.
[49] Satoshi Inoue,et al. Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth. , 2002, Nature.
[50] C. Maki,et al. MDM2 Can Promote the Ubiquitination, Nuclear Export, and Degradation of p53 in the Absence of Direct Binding* , 2001, The Journal of Biological Chemistry.
[51] L. Chua,et al. Methods of Qualitative Theory in Nonlinear Dynamics (Part II) , 2001 .
[52] G. Zachos,et al. Herpes Simplex Virus Type 1 Blocks the Apoptotic Host Cell Defense Mechanisms That Target Bcl-2 and Manipulates Activation of p38 Mitogen-Activated Protein Kinase To Improve Viral Replication , 2001, Journal of Virology.
[53] U Alon,et al. Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[54] Francisca Vazquez,et al. Phosphorylation of the PTEN Tail Regulates Protein Stability and Function , 2000, Molecular and Cellular Biology.
[55] P. Heinrich,et al. Different protein turnover of interleukin-6-type cytokine signalling components. , 1999, European journal of biochemistry.
[56] D. Livingston,et al. Regulation of endogenous E2F1 stability by the retinoblastoma family proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[57] A. Levine,et al. Functions of the MDM2 oncoprotein , 1999, Cellular and Molecular Life Sciences CMLS.
[58] L. Chua,et al. Methods of qualitative theory in nonlinear dynamics , 1998 .
[59] S J Parsons,et al. Overexpression of Cellular Src in Fibroblasts Enhances Endocytic Internalization of Epidermal Growth Factor Receptor* , 1997, The Journal of Biological Chemistry.
[60] E. Solary,et al. Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity. , 1997, Journal of the National Cancer Institute.
[61] A. Shvarts,et al. Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins. , 1996, Genes & development.
[62] D. Lane,et al. On the regulation of the p53 tumour suppressor, and its role in the cellular response to DNA damage. , 1995, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[63] R. Eisenman,et al. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. , 1993, Genes & development.
[64] K. Murakami,et al. c-Ets-1 protein is hyperphosphorylated during mitosis. , 1993, Oncogene.
[65] M. Oren,et al. mdm2 expression is induced by wild type p53 activity. , 1993, The EMBO journal.
[66] C. Finlay,et al. The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth , 1993, Molecular and cellular biology.
[67] Polina S. Landa,et al. Stochastic and Chaotic Oscillations , 1992 .
[68] Baltazar D. Aguda,et al. Bistability in chemical reaction networks: Theory and application to the peroxidase–oxidase reaction , 1987 .
[69] S. E. Khaikin,et al. Theory of Oscillators , 1966 .